Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |